Categories: Hospitals

Sterling Accuris Diagnostics Expands Reach through Strategic Alliance with VPL Diagnostic

New Delhi, India – November 02, 2023 – Sterling Accuris Diagnostics, one of the fastest-growing network of NABL-accredited pathology laboratories, is excited to announce a strategic alliance with VPL diagnostic, a prominent provider of specialty allergy testing services located in Ahmedabad. This strategic alliance further solidifies Sterling Accuris’ strong presence in the diagnostics industry.

VPL diagnostic is a specialized ImmunoCAP & ELISA allergy testing laboratory. With 10+ years of experience in the field of allergy testing, it leverages cutting-edge technology in testing facilities to provide all kinds of allergy tests such as food, drugs, and inhalants. VPL diagnostic also offers a comprehensive pathology test menu. It is consistently expanding and upgrading its capabilities to maintain a competitive edge in the field of allergy testing.

Mr. Rajiv Sharma, MD of Sterling Accuris Diagnostics, expressed that “Sterling Accuris has a comprehensive range of test menu, from basic haematology to high end genetics. VPL diagnostic is a highly specialized lab in the field of allergy testing and has more than 500 clients Pan India. This alliance will help us leverage this network of clients to also provide high-end testing services other than allergy testing to them.”

Mr. Ankush Gupta, CEO of Sterling Accuris Diagnostics, said, “As per Data Bridge Model Research, the Indian Allergy market is expected to undergo a CAGR of 10.9% during the forecast period of 2022-2029. Through this strategic alliance with VPL diagnostic, both companies aim to leverage mutual synergies for strong growth.”

Mr. Unmil Shah, MD of VPL Diagnostic, stated, “VPL Pathology Lab is renowned for our expertise in allergy testing, and our collaboration with Sterling Accuris opens exciting new horizons for us. Sterling Accuris’ extensive network of labs and patient service centers will make our presence across the states, firmly establishing our leadership in the allergy testing domain.”

 Mrs. Nirvi Shah, Head Business Operations of VPL Diagnostic stated, “Alliance with Sterling Accuris will help us consolidate our presence in direct to customer segment.  Collectively both the companies will work towards introducing specific Microarray based allergy testing and food intolerance making VPL diagnostic one stop solution for allergy testing.”

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

World Diabetes Day Survey: Diabetologists and Endocrinologists demand for AI-Based Training and Upskilling in Diabetes Care

 A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…

10 mins ago

Doctors warn diabetes patients about risk of smoking

People who smoke are also at much higher risk of developing diabetes compared to non-smokers…

1 day ago

CPHI & PMEC India Expo: Encouraging affordable solutions in India’s march towards a $130 Billion Pharma Market by 2030

17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…

1 day ago

Sringeri Sharada Equitas Hospital Revolutionizing Cancer Care with the Launch of Low-cost, High Quality Radiation Therapy

The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…

2 days ago